Sign in

CIK 0001840233 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Xilio Therapeutics, Inc.

Sign in to watch
Ticker
XLO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851623397
Phone
617-833-1027
Business address
828 WINTER STREET, WALTHAM, MA, 02451
  1. S-3/A Offering Registration Statement
  2. UPLOAD Other SEC-generated Letter
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  6. SCHEDULE 13G Stake Statement of Beneficial Ownership
  7. S-3 Offering Registration Statement
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. ARS Other Annual Report to Security Holders
  11. DEF 14A Proxy Proxy Statement
  12. 4 Insider Changes in Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 8-K Event Executive or director change
  15. 4 Insider Changes in Ownership
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. 10-K Report Annual Report
  18. 8-K Event Results of operations
  19. 8-K Event Shareholder rights changed · Bylaws or fiscal year change
  20. 8-K Event Regulation FD disclosure

Page 2 of 19 · 361 filings